[Health Valley] Nicolas Durand prend la direction de la Fondation Campus Biotech à Genève

[Health Valley] Nicolas Durand prend la direction de la Fondation Campus Biotech à Genève

The Foundation Campus Biotech announced the appointment of our its new Director, Dr Nicolas Durand. “With an extensive background in nanotechnologies applied to life sciences, Dr Durand brings a wealth of knowledge and expertise that will undoubtedly steer us towards continued success and growth”, states the Foundation Council.

Dr Durand will step down as Director of Abionic, but will remain a member of the company’s Board of Directors. Today, Abionic is recognized as one of Switzerland’s most innovative companies. A spin-off from EPFL (Ecole Polytechnique Fédérale de Lausanne), the company, which received the Swiss Medtech Award 2023, employs around twenty people at the Lausanne Biopôle. Abionic has developed abioSCOPE®, the world’s fastest multipurpose in-vitro diagnostic platform, based on nanotechnology that delivers instant laboratory-quality results. Its technology supplies hospitals in dozens of countries worldwide (Europe, US, Middle East, Asia, Africa, etc.) for various applications in acute and primary care.

Leave a reply